The multiple actions of dipeptidyl peptidase 4 (DPP-4) and its pharmacological inhibition on bone metabolism: a review
Article in Diabetology & Metabolic Syndrome (July 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies
Article in Osteoporosis International (May 2019)
Diabetes pharmacotherapy and effects on the musculoskeletal system
Article in Diabetes/Metabolism Research and Reviews (December 2018)